ABCA1 mutation carriers with low high-density lipoprotein cholesterol are characterized by a larger atherosclerotic...

Area of Science:

• Cardiovascular Medicine
• Genetics
• Biochemistry

Background:

• Low high-density lipoprotein cholesterol (HDL-C) is a significant risk factor for cardiovascular disease (CVD).
• Mutations in ATP-binding cassette transporter A1 (ABCA1), a key regulator of HDL-C, were not previously linked to CVD risk in cohort studies.
• Understanding the impact of ABCA1 dysfunction on atherosclerosis is crucial for CVD prevention.

Purpose of the Study:

• To investigate the consequences of reduced HDL-C due to ATP-binding cassette transporter A1 (ABCA1) dysfunction on atherosclerotic vascular disease in carotid arteries.
• To assess the relationship between ABCA1 mutations, HDL-C levels, and carotid artery wall characteristics.

Main Methods:

• 3.0 Tesla magnetic resonance imaging (MRI) was used to measure carotid artery parameters in 36 carriers of functional ABCA1 mutations and 36 normolipidemic controls.
• Measurements included mean wall area, mean wall thickness, and normalized wall index.
• Statistical analyses were performed, adjusting for multiple cardiovascular risk factors.

Main Results:

• ABCA1 mutation carriers exhibited 42% lower HDL-C levels compared to controls (P < 0.001).
• Carriers showed significantly larger mean wall area (P = 0.02), mean wall thickness (P = 0.005), and normalized wall index (P = 0.005).
• These differences remained significant after adjusting for major cardiovascular risk factors (P = 0.002).

Conclusions:

• Loss-of-function ABCA1 mutations are associated with increased carotid artery atherosclerotic burden, implying a higher CVD risk.
• Further research is needed to fully understand ABCA1's protective role against atherosclerosis.
• These findings support developing strategies to enhance ABCA1 activity in patients with existing CVD.